Canaccord Starts Claritev (CTEV) at Buy, 'Access, affordability, transparency: CTEV smack-dab in the middle of healthcare'

May 29, 2026 6:11 AM

(Updated - May 29, 2026 12:19 PM EDT)

Canaccord analyst Richard Close initiates coverage on Claritev (NYSE: CTEV) with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found